Histologic Response (Tumor Necrosis Rate)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Histologic Response (Tumor Necrosis Rate) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownNot Applicable

NCT03336554

Epigenetic Biomarker for Osteosarcoma

hMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based on selective chemical labeling. It uses β-glucosyltransferase (βGT) to selectively l…

China100 participantsStarted 2017-09-01